Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dendrimer biocompatibility and toxicity.

Ruth Duncan1, Lorella Izzo

  • 1Centre for Polymer Therapeutics, Welsh School of Pharmacy, Cardiff University, Cardiff CF10 3XF, UK. DuncanR@cf.ac.uk

Advanced Drug Delivery Reviews
|November 22, 2005
PubMed
Summary

Biomedical dendrimers show promise as drug delivery systems and therapeutic agents. Their safety profile is application-specific, requiring careful development based on existing polymer knowledge.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bio-Based Polymers with Potential Antimicrobial Activity from Vanillin Methacrylate via ARGET-ATRP.

Polymers·2026
Same author

Bridging the gap in trauma care across New Zealand.

The New Zealand medical journal·2025
Same author

En Route Toward Sustainable Polycarbonates via Large Cyclic Carbonates.

ChemSusChem·2025
Same author

Bio-based production of cis,cis-muconic acid as platform for a sustainable polymers production.

Bioresource technology·2024
Same author

Antimicrobial Polymer Surfaces Containing Quaternary Ammonium Centers (QACs): Synthesis and Mechanism of Action.

International journal of molecular sciences·2024
Same author

Morphology and Mechanics of Star Copolymer Ultrathin Films Probed by Atomic Force Microscopy in the Air and in Liquid.

Materials (Basel, Switzerland)·2024

Area of Science:

  • Biomedical Science
  • Polymer Chemistry
  • Toxicology

Background:

  • Dendrimers are emerging as versatile tools in biomedical applications, including drug delivery and therapeutics.
  • There is growing interest in understanding the toxicological profiles of dendrimers for safe clinical translation.

Purpose of the Study:

  • To review current knowledge on the toxicology of dendrimer chemistries under development for biomedical applications.
  • To guide the development of safe dendritic polymers by leveraging existing clinical experience with polymeric materials.

Main Methods:

  • Literature review of preclinical and clinical data on dendrimer toxicology.
  • Analysis of safety data from related polymeric excipients, plasma expanders, and polymer therapeutics.
  • Assessment of the application-specific nature of dendrimer safety.

Main Results:

  • The safety of dendrimers is not intrinsic but depends on the specific application.
  • Limited clinical data currently prevents definitive classification of any dendrimer chemistry as inherently safe or toxic.
  • Existing knowledge of polymer therapeutics can inform the development of safe dendrimers.

Conclusions:

  • Judicious development of dendrimer chemistry for specific applications is crucial for ensuring safety.
  • Preclinical and clinical experience with polymers supports the potential for developing safe and effective dendrimer-based biomedical materials.
  • Further research and application-specific evaluation are necessary to establish the safety of biomedical dendrimers.

Related Experiment Videos